Circularis Biotechnologies
Biotechnology-Research
Website
Company Tagline
Using circular RNA to control any gene, in any species, in any cell type. "Acquired by Ginkgo Bioworks in 2022"
Industry Category
Business Keywords
Company Description
Circularis Biotechnologies is a dynamic company dedicated to advancing the field of biotechnology research. Specializing in the innovative use of circular RNA, Circularis Biotechnologies has developed a groundbreaking method for studying and regulating gene expression. This technology enables increased bio-therapeutic production, improved targeting of gene therapy, and optimized expression in poorly studied organisms.
Located at 2945 Webster St, Oakland, CA 94609, US, Circularis Biotechnologies is committed to breakthrough solutions without prior knowledge of the regulatory elements or coding sequence. The company’s elegant design and high-throughput approach are setting new standards in the industry.
Circularis Biotechnologies continues to push the boundaries of what's possible in biotechnology. We invite the manager of Circularis Biotechnologies to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.
Circularis Biotechnologies est une entreprise dynamique dédiée à l'avancement de la recherche en biotechnologie. Spécialisée dans l'utilisation innovante de l'ARN circulaire, Circularis Biotechnologies a développé une méthode révolutionnaire pour étudier et réguler l'expression des gènes. Cette technologie permet une production bio-thérapeutique accrue, un ciblage amélioré de la thérapie génique et une expression optimisée dans des organismes peu étudiés.
Située au 2945 Webster St, Oakland, CA 94609, États-Unis, Circularis Biotechnologies s'engage à fournir des solutions révolutionnaires sans connaissance préalable des éléments régulateurs ou de la séquence codante. La conception élégante et l'approche à haut débit de l'entreprise établissent de nouvelles normes dans l'industrie.
Circularis Biotechnologies continue de repousser les limites de ce qui est possible en biotechnologie. Nous invitons le responsable de Circularis Biotechnologies à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en valeur son travail innovant.
Key Personnel / Employees
Compare Companies Side by Side
Compare Circularis Biotechnologies with 3 companies in Biotechnology-Research
| Comparison Field |
Circularis Biotechnologie...Main Company |
LICORbioView Profile |
Syngene Internationa...View Profile |
Fermelanta, Inc.View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1971 | 1993 | 2022 |
|
Company Size
|
— | 201-500 | 5,001-10,000 | 11-50 |
|
City
|
Oakland, CA | Lincoln, NE | Bengaluru, Karnataka | Nonoichi-city, Ishikawa |
|
Country
|
United States | United States | India | |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Circular RNA
Gene Expression
Biotechnology Research
Gene Therapy
Biotherapeutic Production
Molecular Biology
Synthetic Biology
Therapeutic Promoters
Drug Discovery
Biologics
Bioprocessing
Promoter Enhancement
Metabolic Engineering
Promoter Discovery
Protein Expression
|
11 Total
11 Unique
Unique Skills:
Biology
Biotechnology
Cancer Research
Cell Therapy
Life Sciences
Microbiology
+5
|
29 Total
29 Unique
Unique Skills:
Analytical Characterization & Quality Control
Analytical Development
Antibody Drug Conjugates
Antibody Generation
Bioanalytical Laboratory Services
CAR-T
+23
|
3 Total
3 Unique
Unique Skills:
Applied Microbiology
Chemical Engineering
Genetic Engineering
|
4
Total Companies1971
Oldest Founded2
Countries58
Unique SkillsSimilar Companies
Other organizations in the same industry
Typeone Biomaterials S.r.l.
Biotechnology-ResearchBiomaterials from Future
Sisco Research Laboratories Pvt. Ltd. (SRL)
Biotechnology-ResearchEndless process of science
Alternative Company Names
This company is also known as